Yourgene Genomic Services receive ISO 15189:2012 accreditation

Validating its COVID-19 testing and sequencing services, providing assurance of compliance to international standards to deliver quality levels of performance and competence

Manchester, UK – 1 September 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that following assessments by the UK accreditation service (UKAS), it has received ISO 15189:2012 accreditation for its COVID-19 testing and sequencing services, providing assurance that the Company's Citylabs 1.0 laboratory in Manchester, meets internationally recognised gold standards.  

Assessments under UKAS ensure that laboratories meet the relevant requirements including the operation of a quality management system and the ability to demonstrate that specific activities are performed within the criteria set out in the relevant standard. This achievement sets a solid foundation for Yourgene, enabling the Company to have certificates and reports accepted in over 80 countries around the world. ISO 15189:2012 accreditation provides confidence that Yourgene’s medical laboratories deliver quality levels of performance and competence and confirms that the Company is operating a clinical service that is safe, reliable and consistent conveying trust to stakeholders and decision-makers and allows for a more rigorous system in operation.

Lyn Rees, CEO of Yourgene commented: “We are so pleased to have been accredited with this ISO standard as it serves to recognise the quality levels of performance at our Citylab 1.0 laboratory. Being a globally recognised accreditation opens up over 80 countries to Yourgene aiding our global operation.”